CAPREOMYCIN sulfate, powder, 1 g [Sigma-C4142-1G]
NST
SASTAPWDCAP1
Valid Article
Account code:
60200
HS Code:
382290
Last Updated on:
07/11/2024, 19:03:06
Former
Code(s):
SLASZFR0281 SLASCAPR1P- SLASZNL0081
Single use
A single-use device, also referred to as a disposable device, is intended for use on one patient during a single procedure. It is not intended to be reprocessed (i.e., cleaned and disinfected or sterilized).
W0104010699 - Media for mycobacteria cultures - manual & automated (for ast drugs , supplements) - other
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
CAPREOMYCIN sulfate, powder
Article NST in 2021 - No longer part of the drug susceptibility testing of M. tuberculosis complex.
Reserved for TB culture programmes.
Definition
Antimycobacterial used for drug susceptibility testing of M. tuberculosis complex.
Synonym
Capreomycin sulfate, from Streptomyces capreolus
Specifications
Some restricted information has been hidden. Sign in
to see this information
Technical specifications
- Powder
- White to off-white, in solution colourless to faint yellow
- Soluble in water
- Formula : H2O4S.W99
- CAS n° 1405-37-4
Packaging & Labelling
1 g in glass vial
Transport not regulated
Instructions for use
- For the preparation of stock solutions and working solutions, refer to Tuberculosis Culture Laboratory, MSF-ITM, 2014.
- The drug working solution is added to the medium during preparation (agar or LJ) or prior to inoculation (MGIT broth tubes).
Storage
- Recommended storage temperature: -20°C
- Keep container tightly closed in a dry and well-ventilated place
- Avoid exposure and formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed.
- Shelf life: 24 months
- Transport in cold chain conditions
- DEEP FREEZE storage at reception
Classification EC Regulation N° 1272/2008
- Acute toxicity, Inhalation: Category 4, H332
- Acute toxicity, Dermal, Category 4, H312
- Acute toxicity, Oral, Category 4, H302
- Reproductive toxicity, Category 1B, H360
Signal Word
Danger
H302 | Harmful if swallowed |
H312 | Harmful in contact with skin. |
H332 | Harmful if inhaled. |
H360 | May damage fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) |
P202 | Do not handle until all safety precautions have been read and understood. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician if you feel |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P302 + P352 + P312 | IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell. |
P304 + P340 + P312 | IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell |
MSF requirements
Capreomycin is part of the second line drugs used against M. tuberculosis complex. The test is performed to investigate resistance of the mycobacteria to this antibiotic. It can be used for liquid and solid cultures.
Some restricted information has been hidden. Sign in
to see this information
Some restricted information has been hidden. Sign in
to see this information